Form D · Biotechnology

Personalis, Inc.

Menlo Park, CA · CIK 0001527753

Offering snapshot reported Jul 18, 2017 · SEC filing

Reported sold
$12.2M
Offering amount: $15M
Investors reported
37
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 29, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2017Initial$12,225,000No comparison37SEC filing
Dec 30, 2014Initial$29,581,947No comparison32SEC filing
Oct 9, 2013Initial$22,077,923No comparison34SEC filing
Aug 15, 2011Initial$5,006,851No comparison4SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-290963
Convertible Promissory Notes; Preferred Stock issuable upon conversion of Promissory Notes; Common Stock issuable upon conversion of Preferred Stock.
Convertible Promissory Notes

Source: Form D, filed Jul 18, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick Balthrop Director
Andrew Chung Director
Jon Feiber Director
Ken Ludlum Director
Jonathan Mac Quitty Director
Vincent Miles Director
Chris Schaepe Director
Sue Siegel Director
Carol Tillis Executive
John West Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1330 O'brien Drive
Menlo Park, CA, 94025